CVS shares slip even though Q3 earnings and revenues beat estimates, with the company boosting its 2025 EPS outlook.
CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.
CVS Health (CVS) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.09 per share a year ago.
CVS Health's stock falls as a large charge to write off the value of an underperforming business takes the shine off an otherwise strong earnings report.
CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.
CVS Health raised its annual adjusted profit forecast on Wednesday, aided by improved pharmacy revenues, but also announced a $5.73 billion writedown of healthcare businesses including its in-pharmacy MinuteClinics.
CVS Health reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit. The quarterly results cap David Joyner's first full year as CEO of the company, which struggled to drive higher profits and improve its stock performance under Karen Lynch.
CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.
CVS Health is shuttering 16 Oak Street Health Centers, or 7% of the total number of the senior-focused primary care locations the company operates across the U.S.
Over the past ten years, CVS Health stock (NYSE: CVS) has returned $31 billion to shareholders in the form of cash through dividends and buybacks. This shareholder-focused strategy has delivered exceptional results in 2025, with the stock posting a remarkable 81% year-to-date return, representing one of the most dramatic healthcare sector turnarounds after suffering a 42% decline in 2024 and demonstrating the company's successful navigation through post-pandemic challenges.
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.